Dana-Farber Cancer Institute CEO salary and executive pay
Dana-Farber Cancer Institute paid its CEO, Benjamin Ebert MD PhD, $531,515 for the fiscal year ending September 2025. On the return for the fiscal year ending September 2024, the CEO was Laurie H Glimcher MD, paid $2,459,825. Total revenue on that return was $3,917,771,259, up 12.9% from $3,471,594,710 for the fiscal year ending September 2024. Dana-Farber Cancer Institute ranks 228th of 229 hospital systems on this site by CEO pay. Dana-Farber Cancer Institute has 4 Form 990 returns on record, for fiscal years ending 2022 to 2025.
Last updated from IRS e-file data. EIN 04-2263040, Boston, MA.
CEO, fiscal year ending September 2025
$531,515
Highest-paid person, fiscal year ending September 2025
$2,679,650Laurie H Glimcher MDPresident & CEO Emerita
- Total revenue
- $3,917,771,259
- CEO pay vs. peers
- Lowest
Source: Form 990, fiscal year ending September 2025, IRS object ID 202602099349300935.View the filing
Peers: the 183 other hospital systems on this site. Ranked 184th of 184 by top pay as a share of revenue. Pay is 0.01% of revenue, our calculation from the same return. Revenue is Part I, line 12; peers are compared on their latest full-year returns.
Highest-paid people on the latest return
On the latest return, 15 people were paid more than $500,000, 5 of them more than $1 million.
| Name and title | Total |
|---|---|
| Laurie H Glimcher MDPresident & CEO Emerita | $2,679,650 |
| William Hahn MD PHDCOO & EVP | $1,505,365 |
| Michael L ReneyCFO & Assistant Treasurer | $1,269,923 |
| Melany DuvalSVP & Chief Philanthropy Officer | $1,225,210 |
| Craig A Bunnell MD MPH MBAChief Medical Officer | $1,156,546 |
Also paid on the latest return: Jennifer Willcox ESQ (Asst Secretary & General Counsel), $958,038; Robert Soiffer MD (Chief Clinical Program Officer), $953,920; Scott Armstrong MD PHD (Chair of Pediatric Oncology), $927,868; Michael Constantine MD (Milford Med Dir-Hematology/Oncology), $924,769; George D Demetri MD (PROFESSOR), $853,480; Jeffrey Meyerhardt MD MPH (Chief Clinical Research Officer), $844,846; Maria Megdal (SVP Chief Administrative Officer), $757,037; Kevin Haigis PHD (Chief Scientific Officer), $743,856; Barrett J Rollins MD PHD (Sr. Advisor to President & CEO), $625,708; Benjamin Ebert MD PhD (TRUSTEE, PRESIDENT, & CEO (AS OF 10/1/24)), $531,515; Wendy Gettleman (VP of Facilities Management & Real Estate), $492,443; Sylvia A Bartel RPh MHP (SR. VP of Pharmacy & CPO), $462,792; John O Chesley ESQ (Former Officer), $417,704; Patrick McCormick (SVP HOSPITAL TRANSFORMATION), $405,048; Bruce Johnson MD (Former), $332,753; and 1 more.
Also listed in Part VII of the latest return, with no pay reported: Joshua Bekenstein (Trustee & Chairman), Lori Whelan (Trustee, Treasurer), Monica Chandra (Trustee & Secretary), Richard Lubin (Trustee & Vice-Chairman), Afsaneh Beschloss (Trustee), Alison Jaffe (Trustee), Amy Berylson (Trustee), Amy Kyle ESQ (Trustee), Andrew Janower (Trustee), Andrew Kaplan (Trustee), Beth Terrana (Trustee), Betty Ann Blum (Trustee), Bradley Lucas (Trustee), Brian Knez (Trustee), Christopher J Hadley (Trustee), Demond Martin (Trustee), Doug Grip (Trustee), Elizabeth Clymer (Trustee), Elizabeth Rappaport (Trustee (AS OF 1/27/25)), Eric Miller (Trustee), Esta Stecher (Trustee), Fatima Penrose (Trustee), Frank Laukien PHD (Trustee), Frederica Williams (Trustee), Gary Prado (Trustee), and 43 more.
CEO pay by year
Each row is the CEO on that year's return.
| Fiscal year ending | Name and title | Total | Revenue | Source |
|---|---|---|---|---|
| Sep 2025 | Benjamin Ebert MD PhD CEO TRUSTEE, PRESIDENT, & CEO (AS OF 10/1/24) | $531,515 | $3,917,771,259 | Filing |
| Sep 2024 | Laurie H Glimcher MD CEO Trustee, President & CEO | $2,459,825 | $3,471,594,710 | Filing |
| Sep 2023 | Laurie H Glimcher MD CEO Trustee, President & CEO | $2,339,457 | $3,387,587,769 | Filing |
| Sep 2022 | Laurie H Glimcher MD CEO TRUSTEE, PRESIDENT, AND CEO | $3,994,058 | $2,669,084,593 | Filing |
How this pay was reported
The parts of each total, as reported on the return for the fiscal year ending September 2025.
Source: Form 990, fiscal year ending September 2025, IRS object ID 202602099349300935.View the filing
| Part VII | Schedule J | |||||||
|---|---|---|---|---|---|---|---|---|
| Name and title | From org | Other | Base | Bonus | Other | Deferred | Nontaxable | Total |
| Laurie H Glimcher MDPresident & CEO Emerita | $2,313,019 | $366,631 | $1,461,748 | $695,680 | $155,591 | $347,058 | $19,573 | $2,679,650 |
| William Hahn MD PHDCOO & EVP | $1,453,272 | $52,093 | $992,361 | $372,372 | $88,539 | $48,495 | $3,598 | $1,505,365 |
| Michael L ReneyCFO & Assistant Treasurer | $1,217,752 | $52,171 | $832,796 | $316,316 | $68,640 | $48,495 | $3,676 | $1,269,923 |
| Melany DuvalSVP & Chief Philanthropy Officer | $1,154,110 | $71,100 | $830,831 | $257,160 | $66,119 | $48,404 | $22,696 | $1,225,210 |
| Craig A Bunnell MD MPH MBAChief Medical Officer | $1,066,683 | $89,863 | $781,580 | $215,329 | $69,774 | $48,496 | $41,367 | $1,156,546 |
| Benjamin Ebert MD PhDTRUSTEE, PRESIDENT, & CEO (AS OF 10/1/24) | $468,091 | $63,424 | $427,658 | $0 | $40,433 | $48,495 | $14,929 | $531,515 |
These figures come from Dana-Farber Cancer Institute's Form 990 returns, as the IRS publishes them. The methodology page explains how they're chosen. To report an error, email corrections@ceopaycheck.com.
How Dana-Farber Cancer Institute compares
Ranked 228th of 229 hospital systems by CEO pay.
- Previous in this ranking: 227th, Lee Health, $709,634
- Next in this ranking: 229th, UNC Rex Healthcare, $495,574
Closest in revenue among the hospital systems on this site:
PeaceHealth$4,455,419 (CEO), fiscal year ending Jun 2025
Tampa General Hospital$2,944,103 (CEO), fiscal year ending Sep 2025
Franciscan Health$3,036,555 (CEO), fiscal year ending Dec 2024
Children's Hospital of Philadelphia$5,479,580 (CEO), fiscal year ending Jun 2025
Lehigh Valley Health Network$5,806,648 (CEO), fiscal year ending Jun 2025
Common questions
Benjamin Ebert MD PhD (TRUSTEE, PRESIDENT, & CEO (AS OF 10/1/24)) was paid $531,515 for the fiscal year ending September 2025: $468,091 from Dana-Farber Cancer Institute and $63,424 in other compensation (Part VII columns D and F).
The highest-paid person on the latest return was Laurie H Glimcher MD (President & CEO Emerita), at $2,679,650. That is $2,148,135 more than the CEO, Benjamin Ebert MD PhD.
Dana-Farber Cancer Institute paid its CEO, Benjamin Ebert MD PhD, $531,515 for the fiscal year ending September 2025. On the return for the fiscal year ending September 2024, the CEO was Laurie H Glimcher MD, paid $2,459,825. The earliest return on record is for the fiscal year ending September 2022, when the CEO was Laurie H Glimcher MD, paid $3,994,058. By fiscal year end: September 2022, $3,994,058 (Laurie H Glimcher MD); September 2023, $2,339,457; September 2024, $2,459,825; September 2025, $531,515 (Benjamin Ebert MD PhD).
Dana-Farber Cancer Institute's return for the fiscal year ending September 2025 reports total expenses of $3,825,086,627 and total revenue of $3,917,771,259 (Part I, lines 18 and 12), so revenue exceeded expenses by $92,684,632. Expenses were $3,358,144,757 for the fiscal year ending September 2024, so they rose 13.9%. The CEO's pay of $531,515 equals 0.01% of expenses, our calculation.
From the 4 Form 990 returns Dana-Farber Cancer Institute filed with the IRS for fiscal years ending 2022 to 2025. The latest full-year return was filed on July 28, 2026. Schedule J of the fiscal year ending September 2025 return breaks down pay for all 6 people in the pay breakdown above.